UK regulator plans to restrict use of AstraZeneca vaccine

Patients under 30 will be offered a different vaccine because of concerns about blood clots

TASS reported on Tuesday that on Tuesday, The Times newspaper reported that the British medical regulator was considering a possibility to restrict the use of AstraZeneca and Oxford University coronavirus vaccine among young people due to concerns over blood clots.

Such a decision could be made, she said, by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) as early as Tuesday.

Last week, the regulator informed that there were 22 reported cases of dura sinus thrombosis and eight other cases of thrombosis with thrombocytopenia in the country up to and including 24 March. Seven people in the UK who had been vaccinated with the vaccine reportedly died after developing blood clots.

According to the publication’s sources at the MHRA, there is “a growing argument for offering young people – at least under the age of 30 – a different vaccine”.

UK regulator plans to restrict use of AstraZeneca vaccine